BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Sales of Olainfarm in September Increase by 17%

  Preliminary consolidated results of AS Olainfarm for September 2017 show that sales made during this month reached 9.63 million euros.

  October 16, 2017

   · 

  1 min read
• Drug Development

  Aptevo Therapeutics Showcases New Mechanism of Action for Its ADAPTIR Platform at the Inflammation Research Society Meeting

  New Autoimmune Candidate APVO210 Demonstrates Targeted Cytokine Delivery for Application in Various Autoimmune and Inflammatory Diseases.

  October 16, 2017

   · 

  9 min read
• Business

  AzurRx Announces Addition of Dr. Vern Lee Schramm to the Board of Directors

  AzurRx BioPharma announced the appointment of Dr. Vern Lee Schramm to the Board of Directors effective October 10, 2017.

  October 16, 2017

   · 

  3 min read
• Biotech Bay

  Asterias Biotherapeutics Announces $10.4M Registered Direct Offering

  The offering is expected to close on or about October 18, 2017, subject to the satisfaction of customary closing conditions.

  October 16, 2017

   · 

  3 min read
• Drug Development

  Celsion Announces Publication of the HEAT Study Manuscript in the High Impact Journal, Clinical Cancer Research

  The study was published in Clinical Cancer Research, a high impact, peer-reviewed medical journal.

  October 16, 2017

   · 

  11 min read
• Business

  Sarepta Therapeutics to Announce Third Quarter 2017 Financial Results and Recent Corporate Developments on October 25, 2017

  Sarepta will report third quarter 2017 financial results after the Nasdaq Global Market closes on Wednesday, October 25, 2017.

  October 16, 2017

   · 

  1 min read
• Business

  Iradimed to Hold 2017 Third Quarter Financial Results Conference Call on October 30th

  Iradimed will release its 2017 third quarter financial results before the market opens on Monday, October 30th.

  October 16, 2017

   · 

  3 min read
• Pharm Country

  Einstein Researchers Share $9M Grant to Find Anti-Aging Therapies

  Scientists now believe that the Fountain of Youth flows from our genes, or at least from the genes of people who live healthy lives to age 100 or later.

  October 16, 2017

   · 

  4 min read
• Business

  Boston Biomedical Appoints Edgar Braendle, M.D., Ph.D., as Head of Research and Development and Chief Medical Officer

  Boston Biomedical today announced the appointment of Edgar Braendle, M.D., Ph.D., to Executive VP, Head of Research and Development and CMO.

  October 16, 2017

   · 

  4 min read
• Business

  Poxel Announces Third Quarter 2017 Financial Update

  POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced today its cash position for the third quarter of 2017.

  October 16, 2017

   · 

  3 min read